Top Markets
#1 Pleasing Gold Pleasing Gold +1,501.42%
#2 PulseChain PulseChain +58.12%
#3 Ontology Gas Ontology Gas +39.42%
#4 Merlin's Seal BTC Merlin's Seal BTC +33.22%
#5 BOOK OF MEME BOOK OF MEME +30.74%
#6 Neiro Neiro +27.65%
#7 ConstitutionDAO ConstitutionDAO +27.64%
#8 Pump.fun Pump.fun +25.65%
#9 Unit Pump Unit Pump +25.65%
#10 Collect on Fanable Collect on Fanable +24.61%
Coin of the day
Pleasing Gold Pleasing Gold
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Surface Oncology, Inc. Surface Oncology, Inc.

Surface Oncology, Inc.

SURF
Classement en actions #26172
Surface Oncology, Inc. is a clinical-stage biotechnology firm focused on... Surface Oncology, Inc. is a clinical-stage biotechnology firm focused on discovering and developing innovative immuno-oncology treatments for cancer patients in the United States. Its pipeline features a range of antibody-based therapeutics, including NZV930, a fully human IgG4 monoclonal antibody designed to modulate extracellular adenosine production, and SRF617, another human IgG4 monoclonal antibody that aims to block CD39's enzymatic activity, thereby influencing adenosine levels and ATP degradation. Other key candidates include SRF388, which targets interleukin 27; GSK4381562, an antibody aimed at CD112R, an inhibitory protein found on natural killer and T cells; and SRF114, which targets the chemokine receptor CCR8. The company also maintains strategic partnerships, holding a licensing agreement with GlaxoSmithKline Intellectual Property (No. 4) Limited for the development, manufacturing, and commercialization of SRF813-targeting antibodies. Furthermore, it has a separate licensing deal with Vaccinex, Inc. concerning the development, production, and commercialization of antibodies targeting SRF114. Established in 2014, Surface Oncology, Inc. operates from its headquarters in Cambridge, Massachusetts.
Prix de l'action
$1.07
Dernière synchronisation: 2023-09-12
Capitalisation boursière
$42.80M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Surface Oncology, Inc. (SURF)

Catégorie

Healthcare
Historique des dividendes pour Surface Oncology, Inc. (SURF)
Surface Oncology, Inc. (symbole boursier : SURF) a versé un total de 0 dividendes.
Le total des dividendes (ajusté en fonction des divisions d’actions) est de : 0.00
Rendement du dividende (TTM) : 0
Versements de dividendes pour Surface Oncology, Inc. (SURF) de 2026 à 2026
Versements annuels de dividendes
Année Dividende (ajusté pour divisions d’actions) Changez
Pas assez de données pour les dates fournies.
Liste de tous les paiements de dividendes
Année Dividende Changez
Pas assez de données pour les dates fournies.
Dividendes versés par des entreprises similaires ou concurrentes
Entreprise Nombre de paiements de dividendes Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US